Journal Logo

Articles by Björn Nashan

COUNTRY-DEPENDENT OUTCOME DIFFERENCES AFTER KIDNEY TRANSPLANTATION IN FRANCE VS. GERMANY – AN ADDITIONAL ANALYSIS OF THE ATHENA STUDY

Suwelack, Barbara; Thaiss, Friedrich; Sommerer, Claudia; More

Transplantation. 104(S3):S32, September 2020.

Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to Standard Tacrolimus-MPA Regimen in de Novo Kidney Transplant Recipients: Athena 12 months Data on Infections

Dragun, Duska; Suwelack, Barbara; Sommerer, Claudia; More

Transplantation. 102:S128, July 2018.

The Athena Study: 12 Months Safety and Efficacy Data for Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in de Novo Kidney Transplant Patients

Nashan, Björn; Sommerer, Claudia; Suwelack, Barbara; More

Transplantation. 102:S279, July 2018.

Outcomes on Allograft Function after 12 Months with Everolimus Plus either Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA Regimen in De Novo Renal Transplant Recipients: The Athena Study

Schenker, Peter; Sommerer, Claudia; Suwelack, Barbara; More

Transplantation. 102:S280, July 2018.

Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study

Holdaas, Hallvard; de Fijter, Johan W.; Cruzado, Josep M.; More

Transplantation. 101(10):2612-2620, October 2017.

Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation

Grabhorn, Enke; Binder, Thomas M. C.; Obrecht, Denise; More

Transplantation. 99(9):1876-1881, September 2015.

Association Between a Gain-of-Function Variant of PTPN22 and Rejection in Liver Transplantation

Dullin, Raphael; Koch, Martina; Sterneck, Martina; More

Transplantation. 99(2):431-437, February 2015.

Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients

Nashan, Björn; Gaston, Robert; Emery, Vincent; More

Transplantation Journal. 93(11):1075-1085, June 15, 2012.

Immediate Postoperative Intensive Care Treatment of Pediatric Combined Liver-Kidney Transplantation: Outcome and Prognostic Factors

Harps, Egmont; Brinkert, Florian; Ganschow, Rainer; More

Transplantation. 91(10):1127-1131, May 27, 2011.

Indications for and Outcomes After Combined Lung and Liver Transplantation: A Single-Center Experience on 13 Consecutive Cases

Grannas, Gerrit; Neipp, Michael; Hoeper, Marius M.; More

Transplantation. 85(4):524-531, February 27, 2008.

FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

Tedesco-Silva, Helio; Mourad, Georges; Kahan, Barry D.; More

Transplantation. 79(11):1553-1560, June 15th, 2005.

FTY720, A NOVEL IMMUNOMODULATOR: EFFICACY AND SAFETY RESULTS FROM THE FIRST PHASE 2A STUDY IN DE NOVO RENAL TRANSPLANTATION

Tedesco-Silva, Helio; Mourad, Georges; Kahan, Barry D.; More

Transplantation. 77(12):1826-1833, June 27th, 2004.

Ki67, E-CADHERIN, AND p53 AS PROGNOSTIC INDICATORS OF LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS

Rosenau, Jens; Bahr, Matthias J.; von Wasielewski, Reinhard; More

Transplantation. 73(3):386-394, February 15th, 2002.

IMPROVEMENT OF ACUTE AND CHRONIC RENAL DYSFUNCTION IN LIVER TRANSPLANT PATIENTS AFTER SUBSTITUTION OF CALCINEURIN INHIBITORS BY MYCOPHENOLATE MOFETIL

Barkmann, Annette; Nashan, Björn; Schmidt, Hartmut H. J.; More

Transplantation. 69(9):1886-1890, May 15th, 2000.

REPLACEMENT OF CALCINEURIN INHIBITORS BY MYCOPHENOLATE MOFETIL IN LIVER TRANSPLANTED PATIENTS WITH RENAL DYSFUNCTION - RESULTS IN 37 PATIENTS.: Abstract# 213 Poster Board #-Session: P60-I

Schlitt, Hans J.; Barkmann, Annette; Böker, Klaus H.W.; More

Transplantation. 69(8):S168, April 27th, 2000.

BACKGROUND AND PROGNOSTIC IMPLICATIONS OF PERIREPERFUSION TISSUE INJURIES IN HUMAN LIVER TRANSPLANTS: A Panel Histochemical Study1

Kiuchi, Tetsuya; Oldhafer, Karl J.; Schlitt, Hans J.; More

Transplantation. 66(6):737-747, September 27, 1998.

BACKGROUNDS OF EARLY INTRAGRAFT IMMUNE ACTIVATION AND REJECTION IN LIVER TRANSPLANT RECIPIENTS: Impact of Graft Reperfusion Quality

Kiuchi, Tetsuya; Schlitt, Hans J.; Oldhafer, Karl J.; More

Transplantation. 60(1):49-55, July 15, 1995.

Show: